Implantable Cardioverter-Defibrillators

被引：1
|
作者：
Aronow, Wilbert S. [1 ]
机构：
[1] New York Med Coll, Div Cardiol, Dept Med, Valhalla, NY 10595 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2010年 / 17卷 / 06期
关键词：
ventricular tachycardia; ventricular fibrillation; sudden cardiac death; cardioverter-defibrillator; anti-arrhythmic drugs; beta blockers; biventricular pacing; statins; angiotensin-converting enzyme inhibitors; SUDDEN CARDIAC DEATH; TERM-FOLLOW-UP; VENTRICULAR EJECTION FRACTION; WALL MOTION ABNORMALITY; CORONARY-ARTERY-DISEASE; LIPID-LOWERING DRUGS; HEART-FAILURE; HIGH-RISK; BETA-BLOCKERS; NONISCHEMIC CARDIOMYOPATHY;
D O I：
10.1097/MJT.0b013e3181bdc65d
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation. The American College of Cardiology/American Heart Association class I, IIa, and III indications for an AICD are discussed. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/minute. Patients with AICDs should be treated with beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
引用
收藏
页码：E208 / E220
页数：13
相关论文
共 50 条
  • [21] IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS - A GUIDE FOR CLINICIAN
    DAVIDSON, T
    VANRIPER, S
    HARPER, P
    WENK, A
    [J]. HEART & LUNG, 1994, 23 (03): : 205 - 215
  • [22] Implantable cardioverter-defibrillators in dialysis patients
    Mills, Mark T.
    [J]. BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (05) : 187 - 188
  • [23] IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS - IMPLICATIONS FOR THE NONELECTROPHYSIOLOGIST
    PINSKI, SL
    TROHMAN, RG
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (10) : 770 - 777
  • [24] Emergencies related to implantable cardioverter-defibrillators
    Pinski, SL
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (10) : N174 - N180
  • [25] Implantable cardioverter-defibrillators in tetralogy of Fallot
    Khairy, Paul
    Harris, Louise
    Landzberg, Michael J.
    Viswanathan, Sangeetha
    Barlow, Amanda
    Gatzoulis, Michael A.
    Fernandes, Susan M.
    Beauchesne, Luc
    Therrien, Judith
    Chetaille, Philippe
    Gordon, Elaine
    Muhll, Isabelle Vonder
    Cecchin, Frank
    [J]. CIRCULATION, 2008, 117 (03) : 363 - 370
  • [26] IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS AND FITNESS TO DRIVE
    PETCH, MC
    [J]. LANCET, 1994, 343 (8898): : 674 - 674
  • [27] HOW USEFUL ARE IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    FOGOROS, RN
    [J]. POSTGRADUATE MEDICINE, 1992, 92 (01) : 301 - &
  • [28] Implantable cardioverter-defibrillators and hospice care
    Kirk, Timothy W.
    [J]. IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 2007, 26 (04): : 82 - 84
  • [29] MORE ON PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    EMBIL, JM
    GEDDES, JS
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) : 892 - 893
  • [30] Implantable cardioverter-defibrillators: expanding indications
    Naccarelli, GV
    [J]. CURRENT OPINION IN CARDIOLOGY, 2004, 19 (04) : 317 - 322
12345